ClinicalTrials.gov
public full text
Public Domain
Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain
The overall goal of this imaging trial is to evaluate \[18F\]PI-2620, a tau targeted positron emission computed tomography radioligand, in individuals with tauopathies and healthy volunteers (HV).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- [18F]PI-2620 Phase 3 Histopathological Study#863600
- 68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma#1031880
- Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients#1282799
- Taurine Therapy for SSADH Deficiency#903917
- Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis#801264
Record · ID 1186219
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive